An innovative conference on the general principles of recognition and management of drug-induced disease was developed for healthcare professionals (particularly primary care).
The full-day conference used a clinical therapeutic approach and was a cooperative effort of the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Staff College and Georgetown University Medical Center (GUMC).
Linked with the FDA MedWatch postmarketing surveillance initiative, the conference used multiple formats, including didactic presentations, panel discussions, and case discussions led by faculty from various disciplines (e.g., internal and family medicine, psychiatry, clinical pharmacology, dentistry, clinical pharmacy, nursing, epidemiology).
Conference topics included new drug approval, pharmacokinetic/pharmacodynamic considerations, and clinical assessment of adverse drug events.
Tests were administered to participants before and after the conference, and participants completed a conference evaluation.
Mean scores for the pre-and posttests were compared globally and by professional discipline.
Conference evaluations were assessed for responses to eight standardized statements and elicited comments.
After the conference, mean and median test scores were improved both globally and by discipline in comparison to pretest results, with improvement on almost all individual test questions.
Comparison of median scores for the pre-and po...
Mots-clés Pascal : Médicament, Toxicité, Pharmacovigilance, Personnel sanitaire, Congrès, Formation professionnelle, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Drug, Toxicity, Pharmacovigilance, Health staff, Congress, Occupational training, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0286074
Code Inist : 002B02A06. Création : 199608.